Beryllium Sensitization

 

March 2008
NIOSH Docket Number 120

NIOSH has an ongoing program of research on beryllium-related health effects. One of the major goals of this research is to prevent sensitization and chronic beryllium disease (CBD) by developing a better understanding of the exposure factors and work processes associated with increased risk for workers, and to develop effective interventions that will reduce the risk for adverse health effects. NIOSH also conducts genetic research on sensitization and CBD.

Final Document

NIOSH Alert: Preventing Sensitization and Disease from Beryllium Exposure; 2/1/11pdf icon [PDF – 21,661 KB]

Materials Under Evaluation

Draft NIOSH Alert, Preventing Chronic Beryllium Disease and Beryllium Sensitization; 02/01/08pdf icon [PDF – 6,146 KB]

Notice of Draft Document Available for Public Comment; 73 FR 12179; 03/06/08pdf icon [PDF – 534 KB]

Peer Review Comments

Peer Reviewers’ Comments – posted December 31, 2009pdf icon [PDF – 46 KB]

Response to Peer Reviewers’ Comments – posted December 31, 2009pdf icon [PDF – 31 KB]

Response to public comments – posted December 31, 2009pdf icon [PDF – 9,538 KB]

Submissions in order of receipt

Exhibit 1 – Submission from Welch (CPWR: Center for Construction Research and Training) – 3/11/08pdf icon [PDF – 505 KB]

Exhibit 2 – Submission from Hobbs (USEC) – 4/10/08pdf icon [PDF – 223 KB]

Exhibit 3 – Submission from Breysse (Division of Environmental Health Engineering, Department of Environmental Health Sciences) – 4/11/08pdf icon [PDF – 249 KB]

Exhibit 4 – Submission from private person (1) – 5/05/08pdf icon [PDF – 652 KB]

Exhibit 5 – Submission from Woodside (NGK Metals Corporation) – 5/07/08pdf icon [PDF – 676 KB]

Exhibit 6 – Submission from Agrawal (AJJER LLC) – 5/12/08pdf icon [PDF – 4,188 KB]

Exhibit 7 – Submission from Arnett (Copper and Brass Fabricators Council, Inc.) – 5/12/08pdf icon [PDF – 795 KB]

Exhibit 8 – Submission from Wambach (Department of Energy) – 5/12/08pdf icon [PDF – 1,658 KB]

Exhibit 9 – Submission from Warner (Caldera Pharmaceuticals, Inc.) – 5/12/08pdf icon [PDF – 3,784 KB]

Exhibit 10 – Submission from Vandyke (National Jewish Medical and Research Center) – 5/12/08pdf icon [PDF – 2,209 KB]

Exhibit 11 – Submission from Jahn (Savannah River Site) – 5/12/08pdf icon [PDF – 27 KB]

Exhibit 12 – Submission from Weeks (Los Alamos National Laboratory) – 5/12/08pdf icon [PDF – 14 KB]

Exhibit 13 – Submission from private person (2) – 5/12/08pdf icon [PDF – 42 KB]

Exhibit 14 – Submission from private person (3) – 5/12/08pdf icon [PDF – 69 KB]

Exhibit 15 – Submission from Kolanz (Brush Wellman Inc.) – 5/12/08pdf icon [PDF – 22,322 KB]

Exhibit 16 – Submission from Gildersleeve (NGK Metals Corporation) – 05/30/08pdf icon [PDF – 137 KB]

Page last reviewed: July 6, 2010